EUVIMEDEUVIMED entdecken
Crossref

Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem

Gemma L Dickinson, Diane L Phillips, Maria M Posada, Archana Chaudhary, Stephen D Hall

International Journal of Pharmacokinetics · 2017

DOI: 10.4155/ipk-2017-0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacokinetics, 2017. Verfasst von Gemma L Dickinson und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Eli Lilly and Company, inVentiv Health Clinical.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Eli Lilly and Company
  • inVentiv Health Clinical

Zitieren

APA

Dickinson, G. L., Phillips, D. L., Posada, M. M., Chaudhary, A., & Hall, S. D. (2017). Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem. International Journal of Pharmacokinetics. https://doi.org/10.4155/ipk-2017-0005

Vancouver

Dickinson GL, Phillips DL, Posada MM, Chaudhary A, Hall SD. Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem. International Journal of Pharmacokinetics. 2017. doi:10.4155/ipk-2017-0005

BibTeX
@article{Dickinson2017,
  author = {Dickinson, Gemma L and Phillips, Diane L and Posada, Maria M and Chaudhary, Archana and Hall, Stephen D},
  title = {Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem},
  journal = {International Journal of Pharmacokinetics},
  year = {2017},
  doi = {10.4155/ipk-2017-0005}
}
Kostenlos starten →